| Combination therapy of pi3k inhibitor and pd-1 inhibitor |
2023-2-28 |
2023-9-07 |
|
| Isoflavonoid compounds and methods for the treatment of cancer |
2023-1-13 |
2023-5-11 |
|
| Combination therapy |
2022-11-11 |
2023-2-14 |
|
| Preparation of a 1,3,5-triazinyl benzimidazole |
2022-10-03 |
2022-12-01 |
|
| Combination therapy |
2022-9-09 |
2023-1-05 |
|
| (alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 … |
2022-6-21 |
2022-10-13 |
|
| Combination therapy |
2022-5-02 |
2022-8-25 |
|
| Voruciclib dosing regimens and methods of treatment including the same |
2022-4-10 |
2022-10-13 |
|
| PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES (ARLQUILAMINO AND … |
2022-3-21 |
2023-6-21 |
|
| Treatment of kras mutant cancers |
2021-11-19 |
2023-6-22 |
|
| Voruciclib poly morphs and methods of making and using thereof |
2021-10-05 |
2021-12-01 |
|
| Combination therapy |
2021-6-10 |
2023-5-12 |
|
| Combination therapies for high and very high risk mds |
2021-5-26 |
2021-7-29 |
|
| Combination therapies |
2021-3-16 |
2021-9-02 |
|
| Treatment of b cell malignancies |
2021-2-08 |
2021-3-25 |
|
| Treatment of relapsed follicular lymphoma |
2021-2-08 |
2021-3-25 |
|
| Combination therapy |
2021-2-08 |
2021-3-25 |
|
| Combination therapies |
2020-12-15 |
2021-4-08 |
|
| Combination therapy |
2020-9-14 |
2020-10-29 |
|
| Polymorphic forms of 3-[2-butyl-1-(2-diethylamino-ethyl)-1h-benzoimidazol-5-yl] … |
2020-3-09 |
2020-10-08 |
|
| Combination therapy |
2019-12-20 |
2020-6-25 |
|
| Benzimidazole derivatives: preparation and pharmaceutical applications |
2018-12-14 |
2020-8-11 |
2020-8-11 |
| Substituted chroman derivatives, medicaments and use in therapy |
2016-6-07 |
2016-10-06 |
|
| Chroman derivatives, medicaments and use in therapy |
2015-10-26 |
2016-5-19 |
|
| IMIDAZO[1,2-a]PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS |
2014-10-17 |
2015-2-05 |
|
| Compound |
2014-5-20 |
2015-11-18 |
2015-11-18 |
| (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, … |
2013-10-02 |
2014-4-10 |
|
| (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5 … |
2013-9-29 |
2013-12-31 |
|
| (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5 … |
2012-3-27 |
2013-10-17 |
|
| (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and … |
2012-3-27 |
2016-2-02 |
|
| (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl … |
2012-3-27 |
2014-2-05 |
|
| Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
2010-7-06 |
2011-1-13 |
|
| Immunomodulating activities |
2009-8-28 |
2012-4-25 |
|
| Combination of benzimidazole anti-cancer agent and a second anti-cancer agent |
2008-3-07 |
2009-12-16 |
|
| IMIDAZO[1,2-a]PYRIDINE HYDROXYMATE COMPOUNDS THAT ARE INHIBITORS OF HISTONE … |
2006-9-20 |
2010-11-03 |
|
| Heterocyclic compounds |
2006-8-01 |
2012-3-27 |
2012-3-27 |
| Heterocyclic compounds |
2006-3-21 |
2007-3-22 |
|
| Imidazo [1,2-a] pyridine derivatives: production and pharmaceutical use |
2006-3-20 |
2013-6-12 |
2013-6-12 |
| Substituted Chroman Derivatives, Medicines and Therapy |
2005-9-21 |
2014-10-30 |
2014-10-30 |
| Chroman derivatives, medicaments and use in therapy |
2005-9-21 |
2008-11-19 |
|
| Chroman derived compounds & formulations thereof for use in therapy |
2005-5-03 |
2006-3-21 |
|
| Benzimidazole derivatives: preparation and pharmaceutical applications |
2004-9-21 |
2011-2-17 |
2011-2-17 |
| Benzimidazole derivatives: preparation and pharmaceutical applications |
2004-9-21 |
2010-11-30 |
|